Pulling a quality piece (informative, fact-based, etc.) on a ground-breaking treatment does not give a good look to the Daily Kos. Was excited to learn about the blog/forum as a possible source of some interesting info and discourse. Now- not at all.

I politely told him so (in a reply to a tweet of his where he explains why he pulled it).

Geez- am starting to align with the folks that say we are going to need a good marketing/advertising department.

Thanks Ken and Ohm! Would suspect that article will one day soon have a large audience of readers!

GLTA- CGC
_________
Posted On: 09/10/2021 3:54:39 PM
Posted By: KenChowder
Re: pythagoras345 #103413

I really can't believe that Sumner (who is a decent writer) can pump Sotrovimab so hard but then cast a doubting eye on Leron. The commonplace designation of CD10 and CD12 as "failed trials" is like a scarlet letter that cannot be ignored -- it begins to be the only thing visible about the company. If Sumner actually looked at the topline results for CD12 (let alone the cancer prelim results), I think he'd be amazed.

But the arrogance is hard to bear. Who does the guy think he is?